These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 16959448

  • 1. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ, Kim MS, Lee S, Kim JS, Woo JS, Park JS, Hwang SJ.
    Int J Pharm; 2007 Jan 10; 328(2):152-60. PubMed ID: 16959448
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Study of process induced polymorphic transformations in fluconazole drug.
    Desai SR, Dharwadkar SR.
    Acta Pol Pharm; 2009 Jan 10; 66(2):115-22. PubMed ID: 19719043
    [Abstract] [Full Text] [Related]

  • 4. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS, Jin SJ, Kim JS, Park HJ, Song HS, Neubert RH, Hwang SJ.
    Eur J Pharm Biopharm; 2008 Jun 10; 69(2):454-65. PubMed ID: 18359211
    [Abstract] [Full Text] [Related]

  • 5. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
    Park J, Park HJ, Cho W, Cha KH, Kang YS, Hwang SJ.
    Int J Pharm; 2010 Aug 30; 396(1-2):239-45. PubMed ID: 20599602
    [Abstract] [Full Text] [Related]

  • 6. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L, Rodrigues MA, Velaga SP, Matos HA, de Azevedo EG.
    Eur J Pharm Sci; 2009 Aug 12; 38(1):9-17. PubMed ID: 19477273
    [Abstract] [Full Text] [Related]

  • 7. Crystalline polymorphism and molecular structure of sodium pravastatin.
    Martín-Islan AP, Cruzado MC, Asensio R, Sainz-Díaz CI.
    J Phys Chem B; 2006 Dec 28; 110(51):26148-59. PubMed ID: 17181270
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
    Tao T, Zhao Y, Wu J, Zhou B.
    Int J Pharm; 2009 Feb 09; 367(1-2):109-14. PubMed ID: 18930795
    [Abstract] [Full Text] [Related]

  • 10. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
    Chieng N, Zujovic Z, Bowmaker G, Rades T, Saville D.
    Int J Pharm; 2006 Dec 11; 327(1-2):36-44. PubMed ID: 16949221
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of solid-state forms of mebendazole.
    Kumar S, Chawla G, Sobhia ME, Bansal AK.
    Pharmazie; 2008 Feb 11; 63(2):136-43. PubMed ID: 18380400
    [Abstract] [Full Text] [Related]

  • 14. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
    Sui X, Wei W, Yang L, Zu Y, Zhao C, Zhang L, Yang F, Zhang Z.
    Int J Pharm; 2012 Feb 28; 423(2):471-9. PubMed ID: 22183131
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
    Tran TT, Tran PH, Park JB, Lee BJ.
    Arch Pharm Res; 2012 Jul 28; 35(7):1223-30. PubMed ID: 22864745
    [Abstract] [Full Text] [Related]

  • 17. Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: Particle morphology, size and protein stability.
    Du Z, Guan YX, Yao SJ, Zhu ZQ.
    Int J Pharm; 2011 Dec 15; 421(2):258-68. PubMed ID: 22001535
    [Abstract] [Full Text] [Related]

  • 18. Solid-state characterization of fluconazole.
    Alkhamis KA, Obaidat AA, Nuseirat AF.
    Pharm Dev Technol; 2002 Nov 15; 7(4):491-503. PubMed ID: 12503530
    [Abstract] [Full Text] [Related]

  • 19. Solid-state characterization of tacrine hydrochloride.
    Sorrenti M, Catenacci L, Bruni G, Luppi B, Bigucci F, Bettinetti G.
    J Pharm Biomed Anal; 2012 Apr 07; 63():53-61. PubMed ID: 22326286
    [Abstract] [Full Text] [Related]

  • 20. [Crystalline polymorphism of eflucimibe].
    Ribet JP, Pena R, Chauvet A, Patoiseau JF, Autin JM, Segonds R, Basquin M, Autret JM.
    Ann Pharm Fr; 2002 May 07; 60(3):177-86. PubMed ID: 12050596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.